Introduction
By de®nition, a hematopoietic stem cell (HSC) is capable both of unlimited self-renewal and dierentiation into all mature peripheral blood types. Hematopoietic dierentiation can be viewed as a tree with the HSC represented by the trunk (or`stem') and each of the committed progenitors and their more committed progeny represented by the branches. The mechanisms that control whether a HSC self-renews or dierentiates remain a mystery. However, many of the important players in this regulation have been identi®ed. The transcriptional regulation of hematopoiesis has been studied in several dierent organisms and many transcription factors have been identi®ed that specify whether hematopoietic stem cells dierentiate down the myeloid, lymphoid, or erythromegakaryocytic lineages. One of the themes that has grown more apparent over years of study is that the critical pathways that control HSC and their progeny are shared by other stem and progenitor cell types throughout the body and throughout phylogeny. The transcriptional regulation of erythropoiesis, lymphopoiesis and myelopoiesis is already covered in detail in other manuscripts in this issue of Oncogene. This review focuses on components of the cellular microenvironment that regulate HSC dierentiation, and on the gene expression patterns that play a role in maintaining a stem cell in its undierentiated state. These ®ndings are placed into context with other tissue systems and other organisms.
Gene expression patterns

Postulated mechanisms of lineage restriction
As cells dierentiate, there is an orchestrated silencing of some genes and activation of others. Experimental data suggest that pluripotent stem/progenitor cells arè primed' to dierentiate down several dierent lineages by low level transcription of many genes that are characteristic of multiple independent discreet lineages (Billia et al., 2001; Hu et al., 1997) . By single cell RT ± PCR analysis, both erythroid and myeloid gene expression programs are initiated by the same progenitor cell prior to exclusive commitment toward the myeloid or erythroid lineage (Hu et al., 1997) . Although many of the cells analysed shared a speci®c phenotype, the genes expressed in these cells varied. For example, in CD34+lin-primary bone marrow cells, approximately 50% of the cells expressed mRNA for both b-globin (consistent with RBC dierentiation) and myeloperoxidase (MPO, consistent with myeloid dierentiation). These data suggest that the cells werè primed' to dierentiate down either the erythroid or myeloid lineage. None of the cells expressed b-globin in the absence of MPO. However, 40% expressed MPO in the absence of b-globin. These latter ®ndings suggest that some of the cells had already become committed to myeloid dierentiation, or that the expression of bglobin is variable in this population of equipotent population cells. It is not yet known whether the transcripts detected at the single cell level are translated. Current methods do not allow detection of low level protein expression for a single cell.
Another elegant study was performed using single cell gene analysis primarily for genes that encode growth factor receptors (Billia et al., 2001) . The cells analysed were always derived from a four or eight cell cluster that had grown from a single cell in culture. The potential dierentiative stage of the cell analysed was predicted to be the same as that of the other cells in the cluster and only those cells that were members of a cluster in which each of the other cells had the same fate as one another was used. In this way, the gene expression pattern could be correlated with the dierentiation potential of the cells. While for many hematopoietic growth factor receptors, the pattern of gene expression was as expected with a restriction of lineage expression as the cells dierentiated, there was also`promiscuous' gene expression in the most multipotent cells. For example, c-fms, which encodes the M-CSF receptor and is understood to play a role in monocytic dierentiation, was expressed not only in that lineage but also in multipotent cells and in partially committed precursors in the erythroid, megakaryocyte, and neutrophil lineages. Similarly, though IL-7 and IL-2 receptor transcripts are known to be expressed in B and T cells, respectively, they were also expressed in multipotent precursors (Billia et al., 2001 ).
These two studies have been instrumental in proving that more pluripotent hematopoietic cells express genes previously thought to be unique to speci®c lineages. Therefore, two concepts coexist. The ®rst is that there can be a set of genes that function together to maintain stem-cell-ness (or pluripotentiality). Second, what makes stem cells unique from their more committed progeny may be that they express low levels of many dierent genes previously considered to be lineage speci®c, and these cells have not yet permanently turned o these genes. A corollary to this model of lineage speci®cation in which unilineage commitment is prefaced' by a promiscuous phase of multilineage gene expression, is that once lineage commitment has been achieved, the genes expressed in the lineage pathways not taken are permanently silenced. This is consistent with the relatively new understanding of hematopoietic dierentiation as being due not just to speci®c transcription factors acting positively to determine lineage commitment, but also due to those same lineage speci®c transcription factors actively repressing alternate lineage programs. This has been shown to be the case for several transcription factors including GATA1, myb and Pu.1 (Nerlov et al., 2000; Takahashi et al., 2000; Zhang et al., 1999; 2000) . Figure 1 demonstrates schematically the dierent types of gene changes that can occur when a stem cell dierentiates into two dierent daughter cell types that represent commitment towards distinct lineages. This same scheme would also be applicable to any bipotent or pluripotent progenitor cell that dierentiates down at least two separate lineages. A type 1 change in gene expression pattern occurs when a gene is expressed at a relatively high level in stem cells and expressed at low or undetectable levels in the dierentiated progeny (e.g. scl). Type 1 genes would be implicated as playing a role in maintaining the stem cell phenotype and preventing dierentiation. A type 2 change occurs when a gene is expressed at very low or undetectable levels in stem cells and is expressed in both daughter cell types (e.g. CD38). Type 3 genes are expressed at detectable levels in stem cells and are completely inactivated in one daughter cell while being expressed at higher levels in the other daughter cell (e.g. MPO). Type 4 genes are similar to type 3 except expression of these genes is undetectably in stem cells. Because the data suggest that promiscuous low-level gene expression is stochastic a gene that is expressed in some but not all stem cells could potentially evade detection by chance. A caveat regarding this schematic is that type 1 genes, which are stem cell speci®c for the three cell stages shown, may be expressed at high levels at later stages in dierentiation (e.g. scl and notch).
Stochastic versus directed stem cell regulation
Hematopoietic stem cells either self-renew, thereby maintaining stem cell properties, or alternatively, give rise to cells increasingly committed to dierentiation into various hematopoietic lineages. It is unclear if this cell fate decision is controlled by a purely stochastic mechanism or is the result of environmental cues mediated at least in part through speci®c receptor ligand interactions. It is likely that cell fate is in¯uenced both by the stochastic nature of gene expression and by soluble factors and cell-cell interactions. The levels of promiscuous gene expression vary in a random manner, but the presence of speci®c combinations of growth factor receptors, for example, will prime certain cells for induction when and if they are exposed to speci®c growth factor combinations present in the microenvironment.
Specific genes and their regulation
In addition to the relatively low-level expression of multiple`promiscuous' genes, many laboratories have worked to identify genes that appear to be expressed uniquely in hematopoietic stem and progenitor cells and not in mature committed blood cells (Type I above). Multiple experimental techniques have been designed to identify these genes including, but not limited to, analysis of genes that are altered in leukemia and lymphoma by analysis of translocations in human disease (Okuda et al., 1996) , insertional mutagenesis of murine retroviruses (Perkins et al., 1991) , dierential display (Bond et al., 1998) , subtractive PCR hybridization (Tsai et al., 2000) , and microarrays followed by bioinformatic analysis (Phillips et al., 2000) . These studies have progressed with the caveat that the stem cell phenotype is not conferred only by expression of speci®c genes that are uniquely expressed in these cells, but also by the combination of these and other gene products in the cell. Genes that were discovered via analysis of mutation or altered Figure 1 Shown above is a schematic of gene expression pro®les that occur during dierentiation of a hematopoietic stem cell into two daughter cells of dierent hematopoietic lineages. A type 1 change is shown in black, type 2 in slanted stripes, type 3 in gray and type 4 in vertical stripes. See text for explanation expression patterns in leukemia are now known to play critical roles in normal hematopoiesis. Such genes include myb and ets, which are induced by a leukemogenic avian retrovirus in which the myb and ets sequences are fused to form a chimeric protein.
Another critical transcription factor is myc, which is induced by a group of viruses that can transform monocytic cells.
Additional genes identi®ed by these techniques include scl, rbtn2, GATA2 and AML1, each of which has been shown, using murine knock-out experiments, to be necessary for de®nitive hematopoiesis (Okuda et al., 1996; Porcher et al., 1996; Tsai et al., 1994; Yamada et al., 2000; Yamada et al., 1998) . Scl is a helix-loop-helix domain transcription factor that was identi®ed as part of a translocation breakpoint. In addition to a role in early hematopoiesis, scl is also expressed in mature lymphoid and megakaryocytic cells. Rbtn2 (also known as lmo2 or ttg-2) is a lim domain containing protein that functionally interacts with scl and GATA-2. GATA2, a member of the GATA family of zinc ®nger transcription factors, is postulated to play a role in self-renewal of HSC and to prevent their dierentiation (Shivdasani and Orkin, 1996) . AML1, a runt domain containing transcription factor, synergizes with many dierent transcription factors to enhance transcription of multiple genes including, but not limited to, GM ± CSF, MPO, and the B and T cell antigen receptors. However, AML1 can also act in concert with additional proteins to inhibit transcription. Many dierent leukemogenic translocations disrupt normal AML1 activity (Lutterbach and Hiebert, 2000) .
Coordinate gene expression
The multiple approaches taken over many years of study re¯ect the diculty of identifying a cohort of coordinately regulated genes that are expressed uniquely in the relatively rare hematopoietic stem cell subpopulation. As a further complication, many of the genes that some may consider to be stem cell speci®c are also expressed in certain mature blood subpopulations. Even the classic murine stem cell`markers' sca and kit, both of which are expressed on hematopoietic stem and progenitor cells, are also expressed on T lymphocytes and mast cells, respectively. Conversely, some growth factors such as thrombopoietin, are both key regulators of lineage speci®c dierentiation and appear to play a role in hematopoietic stem cell selfrenewal.
Large-scale gene expression analyses have guided us toward the regulatory domains of genes that may be coordinately regulated as they are activated and/or repressed at similar stages of hematopoiesis. However, the analyses of the genome that will reveal the underlying regulatory processes for these genes have not yet been fully elucidated. Bioinformatics approaches, which are necessary to identify potentially shared regulatory domains of coordinately expressed genes, are currently under development. For example, the yeast genome has been analysed for the occurrence of speci®c combinations of transcription factor binding domains in the promoters of genes that are known to be expressed at the same time. Using bioinformatics, the investigators distinguished between coordinately regulated genes and those that were expressed simultaneously, but regulated by alternative mechanisms (Pilpel et al., 2001) . One of the common themes that has emerged from promoter analyses of many of the critical genes for hematopoiesis is that most are TATA less and have GC rich promoter regions that interact with the ubiquitous transcription factor Sp1. Many also contain multiple potential binding domains for the GATA and ets transcription factor families. Given that there is some commonality amongst hematopoietic promoters, gene expression speci®city is achieved by complex protein-protein interactions amongst multiple transcription factors that are themselves expressed at dierent relative levels in a cell type speci®c manner.
Stem cell niche
Regulation of HSC fate involves multiple highly orchestrated pathways that determine the cell cycle status, and gene expression pro®le. This complexity is due in large part to the fact that HSC's do not grow as independent autonomous units. Rather, these cells are surrounded in all dimensions by the marrow microenvironment, which is de®ned by cell-cell interactions, cell-ECM interactions, and exposure to variable concentrations and combinations of soluble factors including cytokines. In addition, the proximity to endothelial cells will aect the local oxygen level. The bone marrow microenvironment is comprised of stromal cells, a diverse population consisting of ®broblasts, smooth muscle cells, endothelial cells and others. These cells not only provide a scaold to the developing stem and progenitor cells, but also produce transmembrane ligands, extracellular matrix components and soluble proteins.
Cell ± growth factor interactions HSC are exposed in situ to many dierent growth factors, some soluble, some bound to ECM and some bound to adjacent cells. Due to the inherent diculty in studying these cells in their microenvironment, most of what we know about how dierent soluble growth factors control HSC fate has been deduced from in vitro studies in which the growth factors are not necessarily introduced at physiological concentrations, in physiological ratios to one another, or for the appropriate amount of time. The primary question that has been addressed is whether we can simulate in vitro the conditions that tell the HSC to self-renew. If this were completely understood and could be performed in vitro, we could then expand small numbers of highly pluripotent HSC for clinical transplantation as well as for other scienti®c studies.
Isolation and testing of soluble factors that mediate ex vivo maintenance and expansion of stem cells has continued to pose a major challenge (reviewed recently in McNiece and Briddell, 2001) . Growth factors that have been shown to enhance the proliferation of early hematopoietic stem and progenitor cells are¯t3, SCF, erythropoietin, IL6 and thrombopoietin (Henschler et al., 1994; Zandstra et al., 1997) . These eects are dependent both on the concentration or each component and on the speci®c combinations of growth factors that are present. For example, amongst the very promising data on ex vivo expansion, the complex of interleukin 6 (IL-6) and soluble IL-6 receptor (IL-6/ sIL-6R), acts in synergy with SCF and Flt3 (Lyman et al., 1993; Small et al., 1994) to expand immature human HSCs. In order to prove that early hematopoietic stem/progenitor cells were expanded, the researchers used a xenogeneic transplant model in which human cells are transplanted into highly immunode®cient mice. The ex vivo expanded human cells were capable of repopulating the immunode®cient mice longterm. The proportion of human CD45+ cells in recipient marrow was 10 times higher in animals that received culture expanded cord blood cells than those that received comparable numbers of fresh cord blood CD34+ cells.
Some soluble growth factors have been shown to confer stem cell survival while inhibiting cell proliferation. A classic example of this is TGFb, which is known to play a role in maintaining HSC in a quiescent stem cell state (Eaves et al., 1991; Fortunel et al., 2000; Jacobsen et al., 1995; Liu et al., 1997; Sitnicka et al., 1996) . For gene therapy studies using retroviruses, proliferation of HSCs, and thus their infection by retroviruses, is enhanced when TGFb activity is inhibited (Dao and Nolta, 1999) . The story of TGFb also brings up another very interesting point regarding the cell microenvironment and`priming of gene expression'. TGFb is a prototypical growth factor that aects hematopoietic cells very dierently depending upon the state of dierentiation of the cells. For myeloid committed progenitor cells, TGFb induces dierentiation while for HSCs, it helps to maintain them in a quiescent undierentiated state. In both cases there is an inhibition of cell cycle activation, and the cell-speci®c eects are due to the dierent relative expression levels of multiple transcription factors.
Additional soluble factors that help to maintain HSCs in culture have been identi®ed via studies that were based on discoveries in drosophila melanogaster and c. elegans. In drosophila, surrounding support cells in the developing gonads restrict the self-renewal, and regulate the number of, germline stem cells. Germline stem cells are a self-renewing population of cells that serve as source of gametes in diverse organisms. Current work suggests that self-renewal is controlled both by somatic signaling and by intracellular mechanisms including dierential gene expression, and the cell cycle machinery. In the drosophila ovary, each GSC division produces a daughter cell GSC that remains in contact with a cluster of somatic support cells called the terminal ®lament. Amongst the control signals received by the mitotically active GSC from adjacent somatic cells are proteins called hedgehog, YB and PIWI, each of which is required for GSC maintenance (Xie and Spradling, 2000) .
There is evidence that homologues of these genes in higher vertebrates play analogous roles in maintaining the pluripotentiality of hematopoietic stem cells in the marrow. For example, receptors and coreceptors for hedgehog ligands (Patched1 and Smoothened) are expressed on normal marrow cells and elements of the hedgehog signaling pathway are involved in the control of hematopoietic dierentiation (Detmer et al., 2000) . Similarly, a human homologue of piwi, called hiwi, is expressed by CD34+ hematopoietic stem and progenitor cells but not by more dierentiated cell populations. Expression of hiwi in a human leukemia cell line results in decreased proliferation suggesting that it may play a role in HSC maintenance (Sharma et al., 2001) 
Cell-cell interactions
In the bone marrow microenvironment, HSCs are in cell-cell contact with stromal cells, committed hematopoietic progenitor cells and other HSCs. Therefore, there is plenty of opportunity for cell-cell signaling. Studies in which HSC were expanded in vitro have shown that contact with stromal cells enhances HSC proliferation (Brouard et al., 1998; Dorshkind, 1990) . HSCs receive messages from adjacent cells via gap junctions (connexins are expressed by developing hematopoietic cells (for recent reviews see MontecinoRodriguez and Dorshkind, 2001; Rosendaal and Krenacs, 2000) and receptor/ligand interactions between adjacent cells. Here, the notch/jagged pathway(s) are focused on.
Notch and jagged are members of a superfamily of highly evolutionarily conserved transmembrane receptors that in¯uence numerous cell-fate decisions in both invertebrates and vertebrates. Throughout the phylogenetic tree, these superfamilies participate in binary cell fate decisions. Members of both the notch and jagged superfamilies are predominantly transmembrane molecules. When a notch family member binds to its ligand (jagged family member), a signal is transferred to cleave the intracellular domain of notch, which then translocates to the nucleus where it interacts with cofactors to aect the transcriptional program.
Notch was originally ideniti®ed as playing a role in regulating cell fate decisions during neuronal end epidermal dierentiation in drosophila development. Notch acts by a local feedback mechanism to induce dierentiation of one cell while simultaneously steering the surrounding cells to an alternative dierentiative fate. This feedback mechanism, which is not yet fully understood, thus acts to amplify small dierences in notch expression between adjacent cells thereby leading them down dierentiative pathways. The speci®c fates that are determined based on notch receptor signaling are dependent upon the developmental history of the notch expressing cell. In hematopoiesis, dierential notch expression plays a role in multiple bipolar cell fate decisions as shown in Figure 2 . In this ®gure, the cell that expresses more notch is shown in black and the default pathway in the absence of notch (or that cell type which dierentiates from the cell that expresses relatively lower levels of notch) is shown in white.
HSC's have higher levels of notch than more committed progenitors (Milner et al., 1994) . Jagged-1, presented both on the surface of bone marrow stromal cells in the microenvironment promotes formation of primitive precursor cell populations (Karanu et al., 2000; Milner and Bigas, 1999; Varnum-Finney et al., 1998; Varnum-Finney et al., 2000; Walker et al., 1999) . Therefore, the committed progenitors may be viewed as the laterally inhibited cells that have been directed to an alternate fate. Thus in myelopoiesis, higher notch levels maintain the cells in a less dierentiated state and decreased notch allows for myeloid dierentiation (Bigas et al., 1998) . In addition dierential notch expression plays a role in multiple bifurcations in the dierentiation tree of hematopoietic dierentiation. For erythromegakaryocytic progenitors, higher levels of notch lead cell towards a megakaryocytic pathway and lack of notch leads cells toward the erythroid pathway (Lam et al., 2000) . In lymphoid dierentiation, dierential notch expression guides cells toward the T cells versus B cell dierentiation pathway (Pui et al., 1999) , the ab versus gd T cell pathway (Washburn et al., 1997) , and also plays a role in determining whether resultant T cells will dierentiate into CD4+ or CD8+ cells (Valdez and Robey, 1999) .
The mechanism by which notch plays a role in these bifurcations is not yet known. However, consistent with the ®nding that speci®cation of cell fate seems to involve the coordinated activation of genes related to one fate and suppression of expression of genes of Figure 2 Shown above is a schematic of several binary decision points at which notch expression has been shown to play a role. At each dierentiation step, cells can dierentiate down one of two dierent fates. Alternatively, the binary decision may be whether or not the stem/progenitor cell should dierentiate. The fate that is taken when notch expression is lacking or decreased is shown with a white arrow pointing to a white cell. The alternative pathway, shown with a gray arrow and a black cell, is taken by the daughter cell when notch expression is high. Small numbers refer to the references on which these data are based and are as follows alternative fates (Lehming et al., 1994; Nerlov et al., 2000; Zhang et al., 1999; Zhang et al., 2000) , notch has been shown to interact with CBP/p300 a multifunctional protein complex which is necessary for the activity of speci®c transcription factors (Florence and McGinnis, 1998; Koyano-Nakagawa et al., 1999) . For example, GATA1 and myb stimulate erythropoiesis and myelopoiesis, respectively and activation of GATA1 or myb inhibits the transcriptional activity of the other. Each of these tissue speci®c transcription factors requires CBP as a coactivator of transcription and there is evidence that levels of CBP/p300 are limiting (Goodman and Smolik, 2000) . It is possible that notch signaling directly aects which of these two transcription factors will prevail in a given cell and that the directed stimulation of cell fate in one cell and the simultaneously lateral inhibition of that fate in adjacent cells is in part mediated by the ability of notch to sequester CBP/p300 in cells in a dierential manner.
Cell-ECM interactions
Extracellular matrix (ECM) is composed of three major classes of molecules: structural proteins such as collagen and elastin, specialized proteins such as ®bronectin and laminin, and proteoglycans which consist of a protein core to which is attached long chains of repeating disaccharide units termed glycosaminoglycans (GAGs). ECM proteins in the BM include ®bronectin, collagen, laminin and cytokines, which can bind to ECM proteins. Similar to assays on the function of various cytokines, ex vivo expansion protocols have been used to assess the role of ECM in HSC regulation. Although this section is focused on the eect of ECM on HSC's, it is important to note that the ECM acts in concert with cell-cell interactions and soluble factors to regulate the HSC.
In general, adhesion of hematopoietic stem and progenitor cells to the marrow ECM inhibits cellular proliferation and prevents apoptosis, both of which would lead to longterm survival of quiescent hematopoietic stem cells. Clues are beginning to emerge regarding how these eects are mediated. For example, binding of integrins on hematopoietic stem or progenitor cells has been shown to lead to increased p27 expression, and p27 halts progression of the cell cycle by inhibiting a cyclin dependent kinase, as discussed in further detail below.
Although there are multiple molecules on the HSC membrane that can mediate signals from the ECM including integrins, immunoglobulin-like molecules, cadherins, selectins, and mucins, I focus here on the integrin molecules (Becker et al., 1999; Coulombel et al., 1997; Levesque and Simmons, 1999; Teixido et al., 1992) . Integrins consist of heterodimers of two transmembrane glycoprotein subunits that are called alpha and beta. There are many dierent alpha and beta subunits and more are yet to be discovered. Several dierent integrins have been identi®ed on hematopoietic stem and progenitor cells, and the dierent heterodimers have dierent ligand speci®city although dierent integrins share some ligands (Coulombel et al., 1997; Teixido et al., 1992) . The best characterized integrin on hematopoietic stem and progenitor cells is alpha4/beta1, a beta1 integrin that is also known as VLA-4 (very late activation antigen 4). VLA-4 binds to ®bronectin in the ECM as well as to VCAM-1 (vascular cellular adhesion molecule 1) on adjacent stromal cells. Fibronectin consists of multiple domains, each with speci®c binding sites for other matrix macromolecules and for receptors on the surfaces of cells. Fibronectin can thus bind simultaneously to collagen, heparin in the ECM and integrins on the surface of various cells.
As for other cell receptor/ECM ligand combinations, the binding of VLA-4 on hematopoietic stem and progenitor cells to ®bronectin serves multiple functions including adhesion of the HSC to the microenvironment, homing of circulating hematopoietic stem and progenitor cells, and also transduction of signals to the intracellular environment via the VLA-4 receptor. The critical role of VLA-4/®bronectin (and VLA-4/VCAM) in homing was shown initially by injecting antibodies against VLA-4 into the circulation of mice and primates (Craddock et al., 1997; Papayannopoulou and Nakamoto, 1993) . In these animals, the hematopoietic stem and progenitor cells exited the marrow into the peripheral blood. As expected, co-injection of anti-VLA4 antibodies along with marrow cells at the time of bone marrow transplantation greatly decreased the ability of hematopoietic stem and progenitor cells to home to the marrow. In addition to hematopoiesis in the bone marrow, analogous eects of integrins on stem cell maintenance have been shown in other tissues including epidermal stem cells in the skin (Jensen et al., 1999; Zhu et al., 1999) . The epidermal stem cells express high levels of b1-integrins and binding of these integrins to ECM proteins inhibits dierentiation.
Stage speci®c cell cycle regulation in early hematopoiesis
The focus of this review has been on transcriptional regulation and on aspects of the stem cell niche that play a role in controlling stem cell fate. However, the stem cells themselves have intrinsic characteristics that dier from other cells including speci®c combinations of nuclear factors, chromosomal modi®cations (Cheung et al., 2000; Kouzarides, 2000; Redner et al., 1999; Tsukiyama and Wu, 1997) and mitotic clocks. These intrinsic clocks, which may in part determine the frequency and number of cell divisions, include telomerase (reviewed in Broccoli et al., 1995; Hay¯ick, 1998; Notaro et al., 1997) and cyclin dependent kinase inhibitors, which have been shown to regulate the cell cycle dierently in stem cells than in more committed progenitor cells.
Cyclin dependent kinases (CDK) regulate the cell cycle at dierent checkpoints. Just as there are several cyclin dependent kinases, there are several CDK inhibitors including p21, p27, and p18. These dierent CDK inhibitors play distinct roles in the regulation of hematopoietic self-renewal and dierentiation. For example, p21 acts to maintain a stem cell in a quiescent stem cell state, while p27 and p18 more speci®cally inhibit cycling of committed progenitor cells (Cheng et al., 2000a , Cheng et al., 2000b . Inhibition of p27 or p18 function leads to a decrease in the cell cycle control of committed hematopoietic progenitors and does not aect hematopoietic stem cells. In vivo competitive repopulation studies show that bone marrow cells from p277/7 mice achieved a higher % engraftment than identically prepared cells from WT control animals (Cheng et al., 2000a) . One possible explanation for these data is that there are more progenitor cells per stem cell derived from the marrow of a p277/7 mouse. In contrast, mice lacking p21 have a larger than normal stem cell pool that, unlike the stem cell pool in wildtype animals, can undergo exhaustion when stressed (Cheng et al., 2000b) . This suggests that p21 normally acts to limit the cycling status of hematopoietic stem cells.
